Source: Υπουργείο Υγείας (CY) Revision Year: 2019 Publisher: Codal-Synto Ltd, 21 Constantinoupoleos Street, 3011 Limassol, Cyprus
Sulvorid 50 mg tablets.
Sulvorid 100 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Sulvorid 50 mg tablets: White, round, convex tablet, with 8 mm diameter imprinted with “50” on one side. Sulvorid 100 mg tablets: White, round, convex tablet, with 10.3 mm diameter. |
Each tablet of Sulvorid 50 mg tablets contains 50 mg levosulpiride.
Each tablet of Sulvorid 100 mg tablets contains 100 mg levosulpiride.
Excipients with known effect: lactose monohydrate.
Each tablet of Sulvorid 50 mg tablets contains 85 mg of lactose monohydrate.
Each tablet of Sulvorid 100 mg tablets contains 170 mg of lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Levosulpiride |
Levosulpiride is a selective antagonist at dopamine (D) receptors. Levosulpiride exerts a regulation action both on the central and peripheral nervous circuits controlling the dynamics of digestive system. |
| List of Excipients |
|---|
|
Microcrystalline cellulose (E460) |
Packs of 20, 30, 60 and 100 tablets packed in blisters (PVC/PVDC/Al or PVC/PCTFE/Al).
Not all pack sizes may be marketed.
Codal-Synto Ltd, 21 Constantinoupoleos Street, 3011 Limassol, Cyprus
M.L.: 022923 (50MG)
M.L.: 022924 (100MG)
27/02/2019
| Drug | Countries | |
|---|---|---|
| SULVORID | Cyprus |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
